February 25th, 2021
Remote FDA Inspection
Increasing Demands of a Digitized World While the Covid-19 pandemic has delivered challenges across the board when it comes to the production of pharmaceutical goods (among other things), it has also thrown governmental programs into disarray. Nowhere is this more clear than in the FDA's own failure to implement a solution for conducting remote inspections, which has drawn sharp criticism from the pharmaceutical industry. At issue is the fact th...